Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Zinan Yi, n/a
Merck
Disclosure(s): Merck: Stocks/Bonds (Public Company)
Poster(s):
(P-658) Cost-Effectiveness of V116, an Adult Specific 21-Valent Pneumococcal Conjugate Vaccine, vs. PCV20 on Pneumococcal Disease in Japan--A Delta-Price Approach
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT
